The Causative Classification System assigned fewer ischemic stroke patients as cause undetermined compared with the TOAST scheme (26.2% vs 39.4%; P<0.000001), whereas ASCO grade 1 did not (P=0.2).
Observational (n=381)
No
Do the CCS and ASCO classification systems reduce the proportion of ischemic stroke patients classified as cause undetermined compared to the TOAST scheme?
The Causative Classification System (CCS) significantly reduces the proportion of ischemic strokes classified as cause undetermined compared to the TOAST scheme, improving etiologic assignment.
Absolute Event Rate: 26.2% vs 39.4%
p-value: p=<0.000001
BACKGROUND AND PURPOSE: Reliable etiologic classification of ischemic stroke may enhance clinical trial design and identification of subtype-specific environmental and genetic risk factors. Although new classification systems (Causative Classification System CCS and ASCO A for atherosclerosis, S for small vessel disease, C for cardiac source, O for other cause) have been developed to improve subtype assignment, few comparative data exist from large studies. We hypothesized that both CCS and ASCO would reduce the proportion of patients classified as cause undetermined compared with the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) scheme in a large population-based stroke study. METHODS: A single rater classified all first-ever ischemic strokes in the North Dublin Population Stroke Study, a population-based study of 294 529 North Dublin residents. Published algorithms for TOAST, CCS, and ASCO were applied. RESULTS: In 381 first-ever ischemic stroke patients, CCS assigned fewer patients as cause undetermined (26.2% versus 39.4%; P<0.000001), with increased assignment of cardio-aortic embolism (relative increase 6.9%; P=0.004), large artery atherosclerosis (relative increase 44.1%; P=0.00006), small artery occlusion (relative increase 27.3%; P=0.00006), and other causes (relative increase 91.7%; P=0.001) compared with TOAST. When ASCO grade 1 evidence was applied, fewer patients were classified as small artery disease (relative decrease 29.1%; P=0.007) and more as large artery/atherothrombotic (relative increase 17.6%; P=0.03). ASCO grade 1 did not reduce the proportion of cause undetermined cases compared with TOAST (42.3% versus 39.4%; P=0.2). Agreement between systems ranged from good (kappa=0.61 for TOAST/ASCO grade 1 small artery category) to excellent (kappa=0.95 for TOAST/CCS and ASCO grade 1/CCS cardio/aorto-embolism category). Application of ASCO grades 1 to 3 indicated evidence of large artery/atherosclerosis (73.3%), cardio-embolism (31.3%), small artery (64.7%), and other cause (12%) in TOAST-undetermined cases. CONCLUSIONS: Both CCS and ASCO schemes showed good-to-excellent agreement with TOAST, but each had specific characteristics compared with TOAST for subtype assignment and data retention. The feasibility of a single combined classification system should be considered.
Marnane et al. (Fri,) conducted a observational in Ischemic stroke (n=381). Causative Classification System (CCS) and ASCO vs. TOAST classification was evaluated on Proportion of patients classified as cause undetermined (p=<0.000001). The Causative Classification System assigned fewer ischemic stroke patients as cause undetermined compared with the TOAST scheme (26.2% vs 39.4%; P<0.000001), whereas ASCO grade 1 did not (P=0.2).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: